28 results
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
activities for the purpose of collective bargaining or other mutual aid or protection or (z) prevents you from discussing or disclosing conduct
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
to engage in concerted activities for the purpose of collective bargaining or other mutual aid or protection or (z) prevents you from discussing
8-K
EX-10.1
KA
Kineta Inc
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement
8-K
EX-10.1
KA
Kineta Inc
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement
8-K
EX-99.6
5e4v5as
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
425
cz9tj6u
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.6
f1nvlcnirdvhez3
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.2
l4ffkdltt13txox
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K/A
EX-99.3
1chlsqsttj5
3 Feb 21
Other Events
4:59pm
8-K
EX-10.1
ze7n3ulj xed
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
425
EX-10.1
02n t5jivqrzf6ek
15 Dec 20
Business combination disclosure
7:32am
8-K
EX-2.1
qsep9
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.1
aaboo31mg q0wc628m87
24 Aug 20
Business combination disclosure
5:28pm
424B5
7izinw oz3p6jh75iyh
9 May 19
Prospectus supplement for primary offering
8:06am